Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tod

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Fundamental & Clinical Pharmacology|December 4, 2008
Evaluation of drugs in pediatrics using K-PD models: perspectivesM Tod
The British Journal of Radiology|March 19, 2010
The size of the vaginal vault in relation to the treatment of cancer of the cervixJ MOORE, M TOD
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Impact of pharmacokinetic-pharmacodynamic model linearization on the accuracy of population information matrix and optimal designY Merlé, M Tod
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1997
Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokineticsM Tod, J M Rocchisani
Journal of Public Health (Oxford, England)|July 23, 2013
Can a nudge keep you warm? Using nudges to reduce excess winter deaths: insight from the Keeping Warm in Later Life Project (KWILLT)Peter Allmark, Angela M Tod
Translational Lung Cancer Research|July 15, 2016
Ethical challenges in conducting clinical research in lung cancerPeter Allmark, Angela M Tod
Computer Methods and Programs in Biomedicine|June 1, 1996
Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteriaM Tod, J M Rocchisani
Clinical Pharmacokinetics|April 5, 2000
Clinical pharmacokinetics and pharmacodynamics of isepamicinM Tod, C Padoin, O Petitjean
Cancer Treatment and Research|January 1, 1995
Drug interaction and pharmacological considerations during anti-infective therapy in cancer patientsO Petitjean, P Nicolas, M Tod
Therapie|January 1, 1993
[Review and use of decision rules for bioequivalence trials]P Nicolas, M Tod, O Petitjean
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Fundamental & Clinical Pharmacology|December 4, 2008
Evaluation of drugs in pediatrics using K-PD models: perspectivesM Tod
The British Journal of Radiology|March 19, 2010
The size of the vaginal vault in relation to the treatment of cancer of the cervixJ MOORE, M TOD
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Impact of pharmacokinetic-pharmacodynamic model linearization on the accuracy of population information matrix and optimal designY Merlé, M Tod
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1997
Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokineticsM Tod, J M Rocchisani
Journal of Public Health (Oxford, England)|July 23, 2013
Can a nudge keep you warm? Using nudges to reduce excess winter deaths: insight from the Keeping Warm in Later Life Project (KWILLT)Peter Allmark, Angela M Tod
Translational Lung Cancer Research|July 15, 2016
Ethical challenges in conducting clinical research in lung cancerPeter Allmark, Angela M Tod
Computer Methods and Programs in Biomedicine|June 1, 1996
Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteriaM Tod, J M Rocchisani
Clinical Pharmacokinetics|April 5, 2000
Clinical pharmacokinetics and pharmacodynamics of isepamicinM Tod, C Padoin, O Petitjean
Cancer Treatment and Research|January 1, 1995
Drug interaction and pharmacological considerations during anti-infective therapy in cancer patientsO Petitjean, P Nicolas, M Tod
Therapie|January 1, 1993
[Review and use of decision rules for bioequivalence trials]P Nicolas, M Tod, O Petitjean
Pageof 13